dentex clinical limited
dentex clinical limited Company Information
Company Number
11513275
Website
www.dentexhealth.co.ukRegistered Address
rosehill new barn lane, cheltenham, GL52 3LZ
Industry
Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
Telephone
443333055631
Next Accounts Due
170 days late
Group Structure
View All
Shareholders
dentex man co limited 100%
dentex clinical limited Estimated Valuation
Pomanda estimates the enterprise value of DENTEX CLINICAL LIMITED at £29.4m based on a Turnover of £20m and 1.47x industry multiple (adjusted for size and gross margin).
dentex clinical limited Estimated Valuation
Pomanda estimates the enterprise value of DENTEX CLINICAL LIMITED at £0 based on an EBITDA of £-6.8m and a 5.58x industry multiple (adjusted for size and gross margin).
dentex clinical limited Estimated Valuation
Pomanda estimates the enterprise value of DENTEX CLINICAL LIMITED at £6.2m based on Net Assets of £3.6m and 1.71x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dentex Clinical Limited Overview
Dentex Clinical Limited is a live company located in cheltenham, GL52 3LZ with a Companies House number of 11513275. It operates in the activities of other holding companies n.e.c. sector, SIC Code 64209. Founded in August 2018, it's largest shareholder is dentex man co limited with a 100% stake. Dentex Clinical Limited is a young, mid sized company, Pomanda has estimated its turnover at £20m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Dentex Clinical Limited Health Check
Pomanda's financial health check has awarded Dentex Clinical Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 6 areas for improvement. Company Health Check FAQs
4 Strong
0 Regular
6 Weak
Size
annual sales of £20m, make it larger than the average company (£16.1m)
£20m - Dentex Clinical Limited
£16.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 408%, show it is growing at a faster rate (4%)
- Dentex Clinical Limited
4% - Industry AVG
Production
with a gross margin of 20.3%, this company has a higher cost of product (34.8%)
20.3% - Dentex Clinical Limited
34.8% - Industry AVG
Profitability
an operating margin of -33.9% make it less profitable than the average company (5.7%)
-33.9% - Dentex Clinical Limited
5.7% - Industry AVG
Employees
with 886 employees, this is above the industry average (102)
886 - Dentex Clinical Limited
102 - Industry AVG
Pay Structure
on an average salary of £21k, the company has a lower pay structure (£39.1k)
£21k - Dentex Clinical Limited
£39.1k - Industry AVG
Efficiency
resulting in sales per employee of £22.5k, this is less efficient (£162.6k)
£22.5k - Dentex Clinical Limited
£162.6k - Industry AVG
Debtor Days
There is insufficient data available for this Key Performance Indicator!
- - Dentex Clinical Limited
- - Industry AVG
Creditor Days
its suppliers are paid after 2 days, this is quicker than average (50 days)
2 days - Dentex Clinical Limited
50 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Dentex Clinical Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 1 weeks, this is less cash available to meet short term requirements (18 weeks)
1 weeks - Dentex Clinical Limited
18 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 97.4%, this is a higher level of debt than the average (69.6%)
97.4% - Dentex Clinical Limited
69.6% - Industry AVG
DENTEX CLINICAL LIMITED financials
Dentex Clinical Limited's latest turnover from March 2022 is £20 million and the company has net assets of £3.6 million. According to their latest financial statements, Dentex Clinical Limited has 886 employees and maintains cash reserves of £1.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|
| Turnover | 19,977,350 | 11,937,941 | 8,700,274 | |
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | -6,766,052 | -2,138,431 | -1,251,063 | |
| Interest Payable | 2,810,471 | 914,131 | 734,475 | |
| Interest Receivable | 0 | 0 | 0 | |
| Pre-Tax Profit | -9,576,523 | -3,052,562 | -1,985,538 | |
| Tax | 0 | 0 | 0 | |
| Profit After Tax | -9,576,523 | -3,052,562 | -1,985,538 | |
| Dividends Paid | 7,553,397 | 6,823,628 | 0 | |
| Retained Profit | -17,129,920 | -9,876,190 | -1,985,538 | |
| Employee Costs | 18,640,006 | 9,646,838 | 8,532,153 | |
| Number Of Employees | 886 | 579 | 440 | 4 |
| EBITDA* | -6,766,052 | -2,138,431 | -1,251,063 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|
| Tangible Assets | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 |
| Investments & Other | 135,041,180 | 73,696,300 | 31,005,885 | 10,426,310 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 135,041,180 | 73,696,300 | 31,005,885 | 10,426,310 |
| Stock & work in progress | 0 | 0 | 0 | 0 |
| Trade Debtors | 0 | 0 | 0 | 1 |
| Group Debtors | 0 | 0 | 0 | 0 |
| Misc Debtors | 925,251 | 934,813 | 1,093,078 | 925,000 |
| Cash | 1,308,387 | 449,147 | 623,244 | 0 |
| misc current assets | 0 | 0 | 0 | 0 |
| total current assets | 2,233,638 | 1,383,960 | 1,716,322 | 925,001 |
| total assets | 137,274,818 | 75,080,260 | 32,722,207 | 11,351,311 |
| Bank overdraft | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 |
| Trade Creditors | 93,760 | 0 | 0 | 0 |
| Group/Directors Accounts | 32,029,095 | 18,403,737 | 12,268,685 | 0 |
| other short term finances | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| other current liabilities | 2,543,424 | 1,192,105 | 413,160 | 0 |
| total current liabilities | 34,666,279 | 19,595,842 | 12,681,845 | 0 |
| loans | 0 | 0 | 0 | 5,545,480 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 |
| other liabilities | 98,967,751 | 49,820,504 | 18,147,514 | 1,927,445 |
| provisions | 0 | 0 | 0 | 0 |
| total long term liabilities | 98,967,751 | 49,820,504 | 18,147,514 | 7,472,925 |
| total liabilities | 133,634,030 | 69,416,346 | 30,829,359 | 7,472,925 |
| net assets | 3,640,788 | 5,663,914 | 1,892,848 | 3,878,386 |
| total shareholders funds | 3,640,788 | 5,663,914 | 1,892,848 | 3,878,386 |
| Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | -6,766,052 | -2,138,431 | -1,251,063 | |
| Depreciation | 0 | 0 | 0 | |
| Amortisation | 0 | 0 | 0 | |
| Tax | 0 | 0 | 0 | |
| Stock | 0 | 0 | 0 | 0 |
| Debtors | -9,562 | -158,265 | 168,077 | 925,001 |
| Creditors | 93,760 | 0 | 0 | 0 |
| Accruals and Deferred Income | 1,351,319 | 778,945 | 413,160 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 |
| Cash flow from operations | -5,311,411 | -1,201,221 | -1,005,980 | |
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | 61,344,880 | 42,690,415 | 20,579,575 | 10,426,310 |
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 13,625,358 | 6,135,052 | 12,268,685 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | -5,545,480 | 5,545,480 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 |
| other long term liabilities | 49,147,247 | 31,672,990 | 16,220,069 | 1,927,445 |
| share issue | ||||
| interest | -2,810,471 | -914,131 | -734,475 | |
| cash flow from financing | 75,068,928 | 50,541,167 | 22,208,799 | |
| cash and cash equivalents | ||||
| cash | 859,240 | -174,097 | 623,244 | 0 |
| overdraft | 0 | 0 | 0 | 0 |
| change in cash | 859,240 | -174,097 | 623,244 | 0 |
dentex clinical limited Credit Report and Business Information
Dentex Clinical Limited Competitor Analysis
Perform a competitor analysis for dentex clinical limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
dentex clinical limited Ownership
DENTEX CLINICAL LIMITED group structure
Dentex Clinical Limited has 83 subsidiary companies.
Ultimate parent company
2 parents
DENTEX CLINICAL LIMITED
11513275
83 subsidiaries
dentex clinical limited directors
Dentex Clinical Limited currently has 3 directors. The longest serving directors include Mr Barry Lanesman (Aug 2018) and Mr Paul Davis (Oct 2023).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Barry Lanesman | United Kingdom | 64 years | Aug 2018 | - | Director |
| Mr Paul Davis | United Kingdom | 49 years | Oct 2023 | - | Director |
| Mr Robert Davidson | Scotland | 47 years | Oct 2023 | - | Director |
P&L
March 2022turnover
20m
+67%
operating profit
-6.8m
+216%
gross margin
20.3%
+6.27%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2022net assets
3.6m
-0.36%
total assets
137.3m
+0.83%
cash
1.3m
+1.91%
net assets
Total assets minus all liabilities
Similar Companies
dentex clinical limited company details
company number
11513275
Type
Private limited with Share Capital
industry
64209 - Activities of other holding companies (not including agricultural, production, construction, distribution and financial services holding companies) n.e.c.
incorporation date
August 2018
age
6
accounts
Audit Exemption Subsidiary
ultimate parent company
previous names
N/A
incorporated
UK
address
rosehill new barn lane, cheltenham, GL52 3LZ
last accounts submitted
March 2022
dentex clinical limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 7 charges/mortgages relating to dentex clinical limited. Currently there are 1 open charges and 6 have been satisfied in the past.
dentex clinical limited Companies House Filings - See Documents
| date | description | view/download |
|---|
